AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MulhollandDrive who wrote (420)	8/17/1997 11:40:00 PM
From: Henry Niman	of 2173

bp, I don't try to time Biotechs. I cited the Zack's report as evidence that in fact AMLN has recently been downgraded by several analyts. Being the #1 Biotech (when it had 5 recs and all 5 were string buys) could produce a somewhat sustained move. 2 Strong Buys and 4 Buys is not stellar (its right in the middle of 115 Biotechs), and I'm not sure how a "speculative buy" would translate, but I would guess its a buy. Thus 2 strong buys and 5 buys isn't much better, so I would think the the AG Edwards report has already run its course on affecting AMLN's price. I also don't expect a wave of upgrades based on Friday's report. If anything, I would look for more downgrades.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next